Norgalax (Docusate Sodium)

Docusate Sodium, the active ingredient in Norgalax, is a surfactant laxative presented as a rectal preparation for OTC use. It works by reducing stool surface tension, allowing water and fat to penetrate, thereby relieving occasional constipation and softening hard stools in adults and elderly patients.

GNH USA supplies Norgalax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for timely delivery.

Norgalax (docusate sodium) is a surfactant laxative used to manage constipation and stool hardness.

- Constipation: softens stool and facilitates easier passage in patients with occasional constipation. - Hard stools: reduces stool hardness, improving comfort during defecation. - Post‑operative bowel care: helps prevent constipation after surgery or periods of reduced mobility.

Norgalax may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mild abdominal cramping or discomfort. - Rectal irritation or mild burning sensation. - Nausea or mild gastrointestinal upset. - Diarrhea or loose stools. - Flatulence or increased gas. - Headache.

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, swelling, or anaphylaxis. - Severe abdominal pain or persistent cramps. - Rectal bleeding not related to administration trauma. - Electrolyte imbalance with prolonged high‑dose use. - Severe dehydration secondary to excessive diarrhea. - Persistent or worsening constipation indicating obstruction.

Before using Norgalax, consider the following safety measures.

- Assess bowel function: ensure the patient does not have an existing obstruction. - Avoid in intestinal blockage: contraindicated in known bowel obstruction or perforation. - Use cautiously in inflammatory bowel disease: monitor for flare‑ups. - Monitor for allergic reactions: discontinue if rash, swelling, or breathing difficulty occurs. - Limit duration: do not exceed the prescriber‑recommended treatment period without medical review. - Store at room temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Docusate sodium may interact with other medications, altering its efficacy or safety.

Major Interactions (Avoid): - Mineral oil: may reduce the stool‑softening effect of docusate. - Cholestyramine or other bile‑acid sequestrants: can bind docusate and diminish absorption.

Moderate Interactions (Monitor Closely): - Oral antibiotics: changes in gut flora may affect stool consistency. - Vitamin supplements (e.g., fat‑soluble vitamins): absorption may be altered. - Diuretics: monitor electrolytes if prolonged laxative use is required.